yes but NZ isn’t listed as a country involved in the registry. so either they are getting commercial patients in Europe and they’re going into registry but as you say Osl hasn’t updated clinical trials.gov, or it really is up to date and they’ve had zero European sales. we should find out soon which it is.
OSL Price at posting:
9.8¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)